Bottom line
FHERX vs FCNTX: the short answer
FHERX (Federated Hermes SDG Engagement Equity Fund) and FCNTX (Fidelity Contrafund) are both mutual funds.
But FCNTX is far broader, holding 441 positions to 58 for FHERX, so beyond the top names it adds exposure FHERX doesn't have.
FCNTX is cheaper at 0.74% vs 0.89% — a difference of $15 a year per $10,000 invested.
Over five years, FCNTX returned +15.5% a year vs +4.7% for FHERX (reporting dates differ).
Updated Nov 19, 2026
FHERX vs FCNTX side by side
| FHERX | FCNTX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Federated Hermes | Fidelity |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.89% | 0.74% |
| Annual cost per $10k | $89 | $74 |
| 10-yr cost on $10k (prospectus) | $1,443 | $918 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.1% | +21.8% |
| 5-yr return (annualized) | +4.7% | +15.5% |
| 10-yr return (annualized) | — | +16.9% |
| Best quarter | — | +26.9% |
| Worst quarter | — | −20.3% |
| Net assets (fund) | $18.4M | $180.0B |
| Number of holdings | 58 | 441 |
| Portfolio turnover | 24% | 29% |
| Returns as of | Dec 31, 2024 | Feb 28, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
FHERX and FCNTX share none of their top holdings.
FHERX top 10
- West Pharmaceutical Services Inc — 3.04%
- Wintrust Financial Corp — 3.00%
- Steris Plc — 2.63%
- Credicorp Ltd — 2.62%
- Viscofan Industria Navarra De Envoltura Celulosicas Sa — 2.58%
- Crane Company — 2.51%
- Aptargroup Inc — 2.48%
- Reinsurance Group Of America Inc — 2.46%
- Ansell Ltd — 2.35%
- Horiba Ltd — 2.24%
FCNTX top 10
- Nvidia Corp — 9.34%
- Meta Platforms Inc — 6.96%
- Space Exploration Technologies Corp — 6.95%
- Amazon.com Inc — 5.75%
- Alphabet Inc — 4.24%
- Berkshire Hathaway Inc Del — 2.75%
- Apple Inc — 2.68%
- Alphabet Inc — 2.60%
- Broadcom Inc — 2.19%
- Microsoft Corp — 2.16%
FAQ
What is the difference between FHERX and FCNTX?
Which is cheaper, FHERX or FCNTX?
Should I own both FHERX and FCNTX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.